12S119: Making the Clinic a One-Stop Shop: In-Office Dispensing

Sunday, November 12, 2023

11:00 AM – 12:00 PM PT

Location: Room 30D-E

CE: 1

Moderator(s)

Madelaine Feldman, MD

THE RHEUMATOLOGY GROUP
New Orleans, LA, United States

Disclosure(s): biogen: Advisor or Review Panel Member (Ongoing); pfizer: Advisor or Review Panel Member (Terminated)

Panelist(s)

AB

Ashley Beall, MD

ARAPC
Bethesda, MD, United States

Disclosure(s): No financial relationships with ineligible companies to disclose
GF

Gary R. Feldman, MD

Pacific Arthritis
Los Angeles, CA, United States

Disclosure(s): No financial relationships with ineligible companies to disclose
KR

Kathleen Rock, PT, MBA

Rock Consulting Inc
Corpus Christi

Disclosure(s): No financial relationships with ineligible companies to disclose
CS

Colin Sheffield, PharmD

Duke University Hospital
Chapel Hill, NC, United States

Disclosure information not submitted.

Speaker(s)

AB

Ashley Beall, MD

ARAPC
Bethesda, MD, United States

Disclosure information not submitted.
GF

Gary R. Feldman, MD

Pacific Arthritis
Los Angeles, CA, United States

Disclosure information not submitted.
CS

Colin Sheffield, PharmD

Duke University Hospital
Chapel Hill, NC, United States

Disclosure(s): No financial relationships with ineligible companies to disclose

In-office dispensing and medically integrated dispensing of rheumatic medications have emerged within the specialty of rheumatology and are now of particular interest as models to provide patients with easier access to conventional disease-modifying agents and biologics. This session aims to differentiate between in-office dispensing and medically integrated dispensing models, define each of these models, and examine the steps needed to implement within an independent rheumatology practice. This session also aims to explore logistics and barriers to include compliance issues. Finally, the goal is to understand how these models have been incorporated into a single specialty group practice.

Learning Objectives:

Compare and contrast in-office dispensing (IOD) and medically integrated dispensing (MID).
Discuss resources needed, factors to consider, and logistical steps when contemplating implementation of IOD and MID into independent practice.
Discuss potential benefits and challenges to each of these models.

Presentations:

11:00 AM – 11:10 AM PT

Overview of In-Office Dispensing and Medically Integrated Dispensing
Speaker: Gary R. Feldman, MD – Pacific Arthritis
11:10 AM – 11:20 AM PT

Understanding In-Office Dispensing and Medically Integrated Dispensing - Is There a Difference?
Speaker: Colin Sheffield, PharmD – Duke University Hospital
11:20 AM – 11:30 AM PT

Strategies for Success: Medically Integrated Dispensing and Your Practice
Speaker: Ashley Beall, MD – ARAPC
11:30 AM – 11:50 AM PT

Panel Discussion
Panelist: Gary R. Feldman, MD – Pacific Arthritis
Panelist: Ashley Beall, MD – ARAPC
Panelist: Kathleen Rock, PT, MBA – Rock Consulting Inc
Panelist: Colin Sheffield, PharmD – Duke University Hospital
Moderator: Madelaine Feldman, MD – THE RHEUMATOLOGY GROUP
11:50 AM – 12:00 PM PT

Q&A